Hospice News September 5, 2024
Enhabit Inc. (NYSE: EHAB) expects consistent hospice growth even as it contends with payer and reimbursement headwinds for its home health business.
The home health and hospice provider recently terminated its home health contract with the Medicare Advantage payer UnitedHealthcare, a subsidiary of UnitedHealth Group (NYSE: UNH), citing nine months of unsuccessful negotiations. In addition, Enhabit and the rest of the home health industry are facing a potential 1.7% rate cut from the U.S. Centers for Medicare & Medicaid Innovation’s proposed 2025 payment rule.
Meanwhile, Enhabit’s hospice segment continues to grow sequentially.
“We’re not under the same reimbursement uncertainty for hospice. Based on the final rule at this point that will go into effect Oct. 1, we expect an approximate...
Today's Sponsors
Today's Sponsor